Other languages ALK-Abelló A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:59 2024-04-26 am EDT			5-day change	1st Jan Change
130 ^DKK	+4.50%		+3.50%	+28.46%

Mar. 14	Transcript : ALK-Abelló A/S - Shareholder/Analyst Call
Mar. 04	New entries in MarketScreener's Europe portfolio

ALK-Abelló A/S: nessuna allergia in vista	Mar. 22
EN DIRECTO DESDE LOS MERCADOS: Inditex, Aena, Acciona Energía, Iberdrola, Rovi, Adidas, Tod's, Volkswagen, CME Group...	Mar. 13
ALK-Abelló A/S: Sin alergia en el horizonte	Mar. 12
Neuzugänge im EU-Portfolio von MarketScreener	Mar. 05
Nuovo acquisto nel portafoglio Europa	Mar. 05
Nieuwe aankopen voor de Europese portefeuille	Mar. 05
Nieuwe aankopen voor de Europese portefeuille	Mar. 05
Nuevas compras en la cartera Inversor Europa	Mar. 04
Nouveaux achats dans le portefeuille Investisseur Europe PEA	Mar. 04
ALK-Abelló A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08
Alk-Abelló A/S Provides Revenue Guidance for the Year of 2024	Feb. 08
ALK-Abelló’s Carbon Reduction Targets Gets Validation from Science-Based Targets Initiative	Feb. 05
Alk's European Registration Application for House Dust Mite Slit-Tablet in Young Children Accepts for Review	Jan. 25
ALK-Abelló’s Peanut Allergy Treatment Shows Safety, Tolerability in First Part of Early-stage Trial	Jan. 18
ALK-Abelló A/S Completes First Part of Phase 1 Trial with Peanut Slit-Tablet	Jan. 18
ALK-Abelló Closes Purchase of US Skin Antigen Test Maker AllerQuest	Jan. 04
ALK-Abelló A/S (CPSE:ALK B) acquired Business Assets of AllerQuest.	Jan. 03
ALK-Abelló A/S Expands Partnership with Torii Pharmaceutical Co., Ltd. in Japan	Dec. 12
Comme un petit vent de prises de bénéfices	Nov. 27
AVIS D'ANALYSTES DU JOUR : Novartis, Inditex, AB Inbev, Aperam, Eutelsat, Euroapi, Alfen...	Nov. 27

No results for this search

ALK-Abelló A/S : No allergy on the horizon

March 12, 2024 at 10:20 am EDT